Effect of Supplementation With HMB and Glutamine in Wound Healing on Bloody Areas

• Status: Not yet recruiting
• Trial end date: 2021-12-31
• Target enrollment: 0
• Participant gender: All

Summary

A randomized controlled clinical trial in two groups of supplementation with HMB and glutamine. Each group consist in 25 patients with bloody areas, one group will receive and intervention with HMB and Glutamine and the other will receive a placebo with calcium caseinate.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Hospital General de Mexico

Criteria

Inclusion Criteria:

• Patients with bloody areas at hospital admission

• Hospital length stay around 15 days

• Medical treatment with surgical washing and negative pressure systems

• For the groups with diabetes, patients with diagnosis of type 2 diabetes with bloody areas.

• Patients that accepts and signs the informative consent.

Exclusion Criteria:

• patients with cancer or immunodeficiency

• patients with HbA1c < 12

• patients with collagen disease

• patients with allergy to intervention substances (HMB, glutamine)